1Praga M,Gutierrez E,Gonzalez E,et al.Treatment of IgA nephropathy with ACE inhibitors:a randomized and controlled trial[J].J Am Soc Nephrol,2003,14(6):1578-1583.
4Bartosik LP,Lajoie G,Sugar L,et al.Predicting progression in IgA nephropathy[J].Am J Kidney Dis,2001,38(4):728-735.
5Russo D,Pisani A,Balletta MM,et al.Additive antiproteinuric effect of converting enzyme inhibitor and losartan in normotensive with IgA nephropathy[J].Am J Kidney Dis,1999,33(5):851-856.
6Nakao N,Yoshimura A,Mmorita H,et al.Combination treatment of angiotensin-Ⅱ receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease(COOPERATE):a randomized controlled trial[J].Lancet,2003,361(9352):117-124.
7Tylicki L,Rutkowski P,Renke M,et al.Renoprotective effect of small doses of losartan and enalapril in patients with primary glomerulonephritis[J].Am J Nephrol,2002,22(4):356-362.
8Efstathios Alexopoulos.Treatment of primary IgA nephropathy[J].Kidney Int,2004,65(3):341-355.
8Lv J,Zhang H,Chen Y,et al. Combination therapy of prednisone and ACE inhibitor versus ACE-inhibitor therapy alone in patients with IgA nephropathy., a randomized controlled trial[J]. Am J Kidney Dis, 2009,53(1):26-32.
9Xu G, Tu W, Jiang D, et al. Mycophenolate mofetil treatment for IgA nephropathy[J]. Am J Nephrol, 2008,29(5) : 362-367.
